Concepts (108)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Microbial Sensitivity Tests | 14 | 2022 | 1877 | 2.360 |
Why?
|
Colistin | 4 | 2022 | 47 | 2.280 |
Why?
|
Klebsiella pneumoniae | 3 | 2022 | 251 | 1.460 |
Why?
|
Anti-Bacterial Agents | 13 | 2022 | 7182 | 1.430 |
Why?
|
Drug Resistance, Multiple, Bacterial | 7 | 2022 | 567 | 1.140 |
Why?
|
Drug Synergism | 6 | 2022 | 1797 | 1.140 |
Why?
|
Vibrio Infections | 2 | 2016 | 34 | 1.110 |
Why?
|
Vibrio parahaemolyticus | 2 | 2016 | 39 | 1.100 |
Why?
|
Water Microbiology | 2 | 2016 | 117 | 1.060 |
Why?
|
Lacerations | 2 | 2016 | 144 | 0.990 |
Why?
|
Wound Infection | 2 | 2016 | 242 | 0.940 |
Why?
|
Candida | 1 | 2021 | 172 | 0.740 |
Why?
|
Enterobacteriaceae | 2 | 2018 | 169 | 0.730 |
Why?
|
Computer Peripherals | 1 | 2019 | 38 | 0.670 |
Why?
|
Coccidioidomycosis | 1 | 2017 | 36 | 0.600 |
Why?
|
Technology, Pharmaceutical | 1 | 2017 | 84 | 0.600 |
Why?
|
Lung Diseases, Fungal | 1 | 2017 | 122 | 0.570 |
Why?
|
Pharyngitis | 1 | 2018 | 215 | 0.550 |
Why?
|
Streptococcal Infections | 1 | 2018 | 638 | 0.460 |
Why?
|
Pharmaceutical Preparations | 1 | 2021 | 1070 | 0.440 |
Why?
|
Virus Diseases | 1 | 2018 | 711 | 0.400 |
Why?
|
Bacterial Infections | 2 | 2019 | 1401 | 0.400 |
Why?
|
Fusidic Acid | 2 | 2019 | 15 | 0.350 |
Why?
|
CADASIL | 1 | 2010 | 84 | 0.340 |
Why?
|
Minocycline | 2 | 2022 | 163 | 0.330 |
Why?
|
Guideline Adherence | 1 | 2018 | 2265 | 0.300 |
Why?
|
beta-Lactamases | 2 | 2019 | 306 | 0.280 |
Why?
|
Rifampin | 2 | 2018 | 315 | 0.280 |
Why?
|
Nerve Degeneration | 1 | 2010 | 748 | 0.260 |
Why?
|
Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization | 2 | 2016 | 504 | 0.240 |
Why?
|
Neuroglia | 1 | 2010 | 928 | 0.240 |
Why?
|
Gene Transfer, Horizontal | 1 | 2022 | 145 | 0.200 |
Why?
|
Anti-Infective Agents | 2 | 2020 | 974 | 0.190 |
Why?
|
Carbapenems | 1 | 2022 | 118 | 0.190 |
Why?
|
Predictive Value of Tests | 1 | 2017 | 15078 | 0.190 |
Why?
|
Quality Control | 2 | 2020 | 841 | 0.180 |
Why?
|
Lincosamides | 1 | 2019 | 4 | 0.180 |
Why?
|
Drug Therapy, Combination | 2 | 2020 | 6489 | 0.170 |
Why?
|
Aminoglycosides | 1 | 2019 | 162 | 0.170 |
Why?
|
Nebramycin | 1 | 2018 | 10 | 0.160 |
Why?
|
Macrolides | 1 | 2019 | 201 | 0.160 |
Why?
|
Klebsiella Infections | 1 | 2019 | 138 | 0.160 |
Why?
|
Aztreonam | 1 | 2017 | 12 | 0.160 |
Why?
|
Glycopeptides | 1 | 2019 | 226 | 0.160 |
Why?
|
beta-Lactams | 1 | 2019 | 160 | 0.150 |
Why?
|
Bacteria | 2 | 2019 | 2115 | 0.150 |
Why?
|
Hyphae | 1 | 2017 | 56 | 0.150 |
Why?
|
Spores, Fungal | 1 | 2017 | 94 | 0.150 |
Why?
|
Fluoroquinolones | 1 | 2019 | 310 | 0.150 |
Why?
|
Endothelium, Vascular | 1 | 2010 | 4458 | 0.150 |
Why?
|
Drug Repositioning | 1 | 2019 | 230 | 0.150 |
Why?
|
Time | 1 | 2019 | 542 | 0.150 |
Why?
|
Azithromycin | 1 | 2018 | 196 | 0.150 |
Why?
|
Acinetobacter Infections | 1 | 2017 | 69 | 0.150 |
Why?
|
Antifungal Agents | 1 | 2021 | 729 | 0.140 |
Why?
|
Acinetobacter baumannii | 1 | 2017 | 107 | 0.140 |
Why?
|
Cephalosporins | 1 | 2016 | 204 | 0.130 |
Why?
|
Automation | 1 | 2017 | 584 | 0.130 |
Why?
|
Drug Combinations | 1 | 2019 | 1958 | 0.120 |
Why?
|
High-Throughput Screening Assays | 1 | 2020 | 944 | 0.120 |
Why?
|
Microscopy | 1 | 2017 | 902 | 0.100 |
Why?
|
Frontal Lobe | 2 | 2007 | 1406 | 0.090 |
Why?
|
Staphylococcus aureus | 1 | 2018 | 1453 | 0.090 |
Why?
|
Staphylococcal Infections | 1 | 2018 | 1400 | 0.080 |
Why?
|
Dementia, Vascular | 1 | 2010 | 129 | 0.080 |
Why?
|
Gene Expression | 1 | 2019 | 7798 | 0.070 |
Why?
|
Anisotropy | 2 | 2007 | 1265 | 0.070 |
Why?
|
Humans | 16 | 2022 | 744376 | 0.070 |
Why?
|
Child | 3 | 2018 | 77708 | 0.060 |
Why?
|
Clinical Trials as Topic | 1 | 2020 | 7914 | 0.060 |
Why?
|
Nerve Fibers, Myelinated | 1 | 2010 | 957 | 0.060 |
Why?
|
Diagnosis, Differential | 1 | 2018 | 12961 | 0.050 |
Why?
|
Self-Injurious Behavior | 1 | 2007 | 464 | 0.050 |
Why?
|
Vascular Diseases | 1 | 2010 | 1161 | 0.050 |
Why?
|
Practice Guidelines as Topic | 1 | 2018 | 7281 | 0.050 |
Why?
|
Brain | 1 | 2006 | 26386 | 0.040 |
Why?
|
Borderline Personality Disorder | 1 | 2007 | 736 | 0.040 |
Why?
|
Methicillin | 1 | 2018 | 59 | 0.040 |
Why?
|
Methicillin Resistance | 1 | 2018 | 198 | 0.040 |
Why?
|
Plasmids | 1 | 2022 | 2308 | 0.040 |
Why?
|
Female | 5 | 2018 | 380200 | 0.040 |
Why?
|
Laboratories | 1 | 2020 | 463 | 0.030 |
Why?
|
Child, Preschool | 1 | 2018 | 41005 | 0.030 |
Why?
|
Vancomycin | 1 | 2018 | 501 | 0.030 |
Why?
|
Diagnostic Tests, Routine | 1 | 2020 | 783 | 0.030 |
Why?
|
Gene Expression Profiling | 1 | 2010 | 9445 | 0.030 |
Why?
|
Pilot Projects | 1 | 2006 | 8319 | 0.030 |
Why?
|
Adolescent | 2 | 2018 | 85784 | 0.020 |
Why?
|
Middle Aged | 3 | 2017 | 213388 | 0.020 |
Why?
|
Male | 2 | 2018 | 350118 | 0.020 |
Why?
|
Quality Assurance, Health Care | 1 | 2020 | 2212 | 0.020 |
Why?
|
Retrospective Studies | 1 | 2018 | 77459 | 0.020 |
Why?
|
Animals | 1 | 2019 | 168770 | 0.020 |
Why?
|
Space Perception | 1 | 2007 | 475 | 0.010 |
Why?
|
Magnetic Resonance Imaging | 1 | 2006 | 35424 | 0.010 |
Why?
|
Reproducibility of Results | 1 | 2016 | 19905 | 0.010 |
Why?
|
Psychomotor Performance | 1 | 2007 | 1901 | 0.010 |
Why?
|
Visual Perception | 1 | 2007 | 1420 | 0.010 |
Why?
|
Prospective Studies | 1 | 2022 | 53291 | 0.010 |
Why?
|
Aged | 1 | 2010 | 163284 | 0.010 |
Why?
|
Data Interpretation, Statistical | 1 | 2007 | 2716 | 0.010 |
Why?
|
Psychiatric Status Rating Scales | 1 | 2007 | 6038 | 0.010 |
Why?
|
Time Factors | 1 | 2017 | 40077 | 0.010 |
Why?
|
Adult | 2 | 2007 | 214056 | 0.010 |
Why?
|
Diffusion Magnetic Resonance Imaging | 1 | 2007 | 2737 | 0.010 |
Why?
|
Neuropsychological Tests | 1 | 2007 | 6994 | 0.010 |
Why?
|
Image Interpretation, Computer-Assisted | 1 | 2007 | 3326 | 0.010 |
Why?
|
United States | 1 | 2020 | 69869 | 0.010 |
Why?
|
Concepts
(108)
Derived automatically from this person's publications.
Explore
_
Co-Authors
(14)
People in Profiles who have published with this person.
Explore
_
Similar People
(60)
People who share similar concepts with this person.
Explore
_
Same Department
People in same department with this person.
Explore
_